2-AG	2-Arachidonoylglycerol
3-NP	3-Nitropropionic acid
5-HT1A	5-Hydroxytryptamine
AchE	Acetylcholinesterase
ACPA	Arachidonyl-cyclopropyl amide
AD	Alzheimer’s Disease
AEA	Anandamide
ALS	Amyotrophic lateral sclerosis
APP	Amyloid precursor protein
BBB	Blood–Brain Barrier
BLA	Basolateral amygdala
CA1	Dorsal hippocampus
CB1R	Cannabinoid-receptors type 1
CB2R	Cannabinoid-receptors type 2
CBD	Cannabidiol
CBD-DMH	Cannabidiol dimethylheptyl
CBG	Cannabigerol
CBR	Cannabinoid receptor
CIDP	Chronic inflammatory demyelinating polyneuropathy
CNS	Central nervous system
COX	Cyclooxygenase
DMT	Disease modifying therapy
EAE	Experimental autoimmune encephalomyelitis
ECB	Endocannabinoid
ECS	Endocannabinoid system
FAAH	Fatty acid amide hydrolase
GABA	Gamma-aminobutyric acid
GBS	Guillain–Barré syndrome
GPRC	G-Coupled protein receptor
GSK-3β	Glycogen synthase kinase-3β
HD	Huntington’s Disease
HTT	Huntingtin
IL	Interleukin
i.p.	Intraperitoneal
L-DOPA	Levodopa
MAGL	Monoacylglycerol lipase
MAPK	Mitogen-activated protein kinases
MCA	Middle cerebral artery
MHC	Major histocompatibility complex
mHTT	Mutant huntingtin
MOG	Myelin oligodendrocyte glycoprotein
MPTP	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
MS	Multiple Sclerosis
MSN	Medium spiny neurons
NAc	Nucleus accumbens
NAPE-PLD	N-arachidonoyl phosphatidylethanolamine-specific phospholipase D
NF-kB	Nuclear factor-kB
NMDA	N-Methyl-D-aspartic acid
NTF	Neurofibrillary tangles
OKA	Okadaic acid
PD	Parkinson’s Disease
PEA	Palmithoylethanolamide
PFC	Prefrontal cortex
PG	Prostaglandin
PKA	Protein kinase A
PPMS	Primary-progressive MS
PRMS	Progressive-relapsing MS
ROS	Reactive oxygen species
RRMS	Relapsing-remitting MS
SPMS	Secondary-progressive MS
TMEV	Theiler’s murine encephalomyelitis virus
TNF-α	Tumor necrosis factor-α
TRPV	Transient receptor potential vanilloid
VTA	Ventral tegmental area
Δ9-THC	Δ9-Tetrahydrocannabinol